Skip to content
OpenCapital
Get started

DocGo DCGO Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value at other companies

Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
——
SRT
Strata Critical Medical, Inc. Class A Common StockSRTA
——
Medline, Inc. logo
Medline, Inc. MDLN
——

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%—
Net margin-62.2%—
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%—
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value?
DocGo (DCGO) reported share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value of $0 in Q1 2026.
How has DocGo's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value changed year-over-year?
DocGo's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value decreased by 100.0% year-over-year, from $830.31K to $0.
What is the long-term trend for DocGo's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value?
Over 5 years (2020 to 2025), DocGo's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value has grown at a -100.0% compound annual growth rate (CAGR), from $8.13M to $0.